Aprepitant and Fosaprepitant for Preventing Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy-A Real-World Study. [PDF]
Ünlü B +8 more
europepmc +1 more source
Therapeutic Use of Medical Cannabis Beyond Pain Management in Physical Medicine and Rehabilitation. [PDF]
Cameron A, Fraix MP, Agrawal DK.
europepmc +1 more source
Risk prediction models for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis. [PDF]
Xie X +5 more
europepmc +1 more source
Revisiting the Role of Lorazepam as an Adjunct in the Management of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]
Peng TR, Lin HH, Wu TW, Hsu CY.
europepmc +1 more source
Phase III Trial: Single Low-Dose 5 mg Dexamethasone with NEPA for Preventing 168 h Nausea and Vomiting of Diverse Highly or Moderately Emetogenic Chemotherapy (LD-NEPA). [PDF]
He Y +9 more
europepmc +1 more source
Investigating the effects of olanzapine on appetite and weight in patients with cancer in a systematic review. [PDF]
Renaux Torres MC +12 more
europepmc +1 more source
Efficacy and safety of transcutaneous electrical acupoint stimulation and acupressure in alleviating chemotherapy-related adverse reactions in female patients with breast cancer: a randomized clinical trial. [PDF]
Yuan J +12 more
europepmc +1 more source
Olanzapine Use and Vomiting Incidence in Chemotherapy-receiving Patients With Cervical Cancer: Multicenter Post Hoc Analysis. [PDF]
Kawamura Y +17 more
europepmc +1 more source
Megestrol acetate versus dexamethasone to prevent nausea and vomiting in patients with gastric or gastro-oesophageal junction cancer treated with oxaliplatin-based chemotherapy: study protocol of a multicentre, randomised, non-inferiority trial. [PDF]
Luo H +8 more
europepmc +1 more source
Moving beyond promethazine: Advancing precision in antiemetic therapy. [PDF]
Ryan MF, Lagasse C.
europepmc +1 more source

